Q9UPY8
Gene name |
MAPRE3 |
Protein name |
Microtubule-associated protein RP/EB family member 3 |
Names |
EB1 protein family member 3 , EBF3 , End-binding protein 3 , EB3 , RP3 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:22924 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
1-130 (CH domain) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

8 structures for Q9UPY8
186 variants for Q9UPY8
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
COSM1494928 | 2 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs746360555 | 3 | V>I | No |
ExAC TOPMed gnomAD |
|
rs112647020 | 5 | V>A | No | Ensembl | |
rs1667123662 | 5 | V>M | No | Ensembl | |
TCGA novel | 6 | Y>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1667123838 | 8 | T>P | No | TOPMed | |
rs780532608 | 12 | S>G | No |
ExAC gnomAD |
|
rs1058547 | 13 | E>G | No | Ensembl | |
rs1058547 | 13 | E>V | No | Ensembl | |
rs1480315869 | 17 | R>C | No | gnomAD | |
rs1175991309 | 18 | H>R | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs1667124477 | 20 | M>I | No | gnomAD | |
rs1292949697 | 20 | M>V | No | gnomAD | |
TCGA novel | 23 | W>* | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs1253236181 | 24 | V>I | No | gnomAD | |
rs768144243 | 26 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA gnomAD |
TCGA novel | 28 | L>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs151223078 | 31 | N>T | No |
ESP ExAC TOPMed gnomAD |
|
rs747545412 | 32 | Y>C | No |
ExAC TOPMed gnomAD |
|
rs1343200551 | 32 | Y>H | No | TOPMed | |
rs1667125310 | 33 | T>A | No | Ensembl | |
rs936126887 | 35 | I>T | No | TOPMed | |
COSM291041 | 40 | S>= | Variant assessed as Somatic; LOW impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1667151970 | 42 | A>S | No | Ensembl | |
rs1335938741 | 43 | A>D | No | gnomAD | |
rs376817083 | 43 | A>T | No |
ESP ExAC TOPMed gnomAD |
|
rs1403639208 | 46 | Q>* | No | gnomAD | |
rs987173228 | 49 | D>G | No |
TOPMed gnomAD |
|
rs1454339408 | 50 | M>V | No | gnomAD | |
rs1361502324 | 53 | P>L | No | gnomAD | |
rs145294178 | 54 | G>R | No |
ESP ExAC TOPMed gnomAD |
|
rs145294178 | 54 | G>S | No |
ESP ExAC TOPMed gnomAD |
|
TCGA novel | 55 | C>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs972575130 | 57 | H>L | No | TOPMed | |
rs1203593461 | 57 | H>Y | No |
TOPMed gnomAD |
|
COSM1019460 | 63 | F>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1237736375 | 66 | K>R | No | gnomAD | |
rs1667153635 | 68 | E>G | No | TOPMed | |
rs1175651354 | 73 | H>Q | No | gnomAD | |
rs762060504 | 73 | H>Y | No |
ExAC TOPMed gnomAD |
|
TCGA novel | 74 | N>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1229397083 | 75 | F>C | No | TOPMed | |
rs1427054781 | 75 | F>L | No | gnomAD | |
rs1334524461 | 83 | K>R | No |
TOPMed gnomAD |
|
rs1344894599 | 86 | G>C | No |
TOPMed gnomAD |
|
rs146112641 | 86 | G>D | No | 1000Genomes | |
rs1667154601 | 87 | V>A | No | TOPMed | |
rs1192636314 | 92 | P>S | No | gnomAD | |
rs1346532640 | 97 | V>E | No | TOPMed | |
COSM1407327 | 98 | K>E | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1429139201 | 100 | K>R | No | gnomAD | |
rs1667178236 | 106 | E>* | No | Ensembl | |
rs1408942151 | 107 | F>C | No | gnomAD | |
rs373095267 COSM1019461 |
114 | F>L | Variant assessed as Somatic; MODERATE impact. large_intestine endometrium [NCI-TCGA, Cosmic] | No |
NCI-TCGA Cosmic cosmic curated ESP ExAC NCI-TCGA TOPMed gnomAD |
rs780104460 | 117 | A>T | No |
ExAC TOPMed gnomAD |
|
rs746905944 | 119 | Y>C | No |
ExAC gnomAD |
|
rs201632549 | 119 | Y>H | No | 1000Genomes | |
rs1337816916 | 123 | D>N | No | gnomAD | |
TCGA novel COSM1407328 |
125 | N>S | Variant assessed as Somatic; MODERATE impact. Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA |
COSM574793 rs1401250016 |
127 | L>V | lung Variant assessed as Somatic; MODERATE impact. [Cosmic, NCI-TCGA] | No |
cosmic curated NCI-TCGA gnomAD |
rs1667179104 | 129 | A>T | No | TOPMed | |
rs377561900 | 129 | A>V | No |
ESP ExAC TOPMed gnomAD |
|
rs1230874000 | 130 | R>G | No | gnomAD | |
rs749554114 COSM1019462 |
130 | R>Q | Variant assessed as Somatic; MODERATE impact. endometrium [NCI-TCGA, Cosmic] | No |
NCI-TCGA Cosmic cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
COSM3580473 rs1230874000 |
130 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA gnomAD |
TCGA novel | 132 | G>A | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs774310199 | 132 | G>S | No |
ExAC gnomAD |
|
rs1667179714 | 134 | D>H | No | Ensembl | |
rs776126217 | 135 | V>I | No |
ExAC gnomAD |
|
rs761152460 | 136 | A>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs1667180305 | 137 | P>S | No |
TOPMed gnomAD |
|
COSM442726 | 138 | P>A | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs761464811 | 138 | P>L | No |
ExAC TOPMed gnomAD |
|
rs1378583508 | 138 | P>S | No | gnomAD | |
rs1667180603 | 139 | P>T | No | Ensembl | |
rs1572775500 | 140 | N>T | No | Ensembl | |
rs1157660970 | 142 | G>D | No |
TOPMed gnomAD |
|
rs764874678 | 145 | I>N | No |
ExAC gnomAD |
|
rs1667181172 | 147 | N>S | No | Ensembl | |
rs2148229822 | 151 | K>N | No | Ensembl | |
TCGA novel | 151 | K>N | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs750037330 | 152 | L>P | No |
ExAC gnomAD |
|
rs757984031 | 153 | I>T | No |
ExAC TOPMed gnomAD |
|
rs138427247 | 154 | G>S | No |
ESP ExAC TOPMed gnomAD |
|
rs754926439 | 155 | T>I | No |
ExAC gnomAD |
|
rs865942631 | 157 | V>I | No | Ensembl | |
rs1421594932 | 158 | P>L | No | gnomAD | |
rs1667220469 | 159 | Q>R | No | gnomAD | |
rs919202118 | 161 | T>A | No | Ensembl | |
rs140237898 | 161 | T>M | No |
ESP ExAC TOPMed gnomAD |
|
rs774010624 | 162 | S>P | No |
ExAC TOPMed gnomAD |
|
TCGA novel | 165 | G>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs975397856 | 168 | N>H | No | Ensembl | |
rs984651965 | 168 | N>I | No | TOPMed | |
TCGA novel | 168 | N>T | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs910285704 | 169 | M>T | No |
TOPMed gnomAD |
|
rs188015519 | 170 | Q>K | No | 1000Genomes | |
rs1343140107 | 171 | T>I | No | TOPMed | |
rs556886277 | 173 | G>S | No |
ExAC gnomAD |
|
rs752718112 | 174 | R>Q | No |
ExAC TOPMed gnomAD |
|
rs1230161170 | 174 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs144585951 | 177 | N>K | No |
ESP ExAC gnomAD |
|
rs1667221663 | 177 | N>Y | No | Ensembl | |
rs943139821 | 178 | V>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
Ensembl NCI-TCGA |
TCGA novel | 179 | A>P | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
COSM1407329 rs763967601 |
179 | A>P | large_intestine [Cosmic] | No |
cosmic curated ExAC TOPMed gnomAD |
rs751778500 | 180 | P>A | No |
ExAC TOPMed gnomAD |
|
rs1165501291 | 180 | P>H | No | Ensembl | |
rs751778500 | 180 | P>T | No |
ExAC TOPMed gnomAD |
|
rs755091160 | 181 | P>A | No |
ExAC TOPMed gnomAD |
|
rs781227628 | 181 | P>H | No |
ExAC TOPMed gnomAD |
|
TCGA novel | 181 | P>L | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs781227628 | 181 | P>L | No |
ExAC TOPMed gnomAD |
|
rs781227628 | 181 | P>R | No |
ExAC TOPMed gnomAD |
|
rs755091160 | 181 | P>S | No |
ExAC TOPMed gnomAD |
|
rs755091160 | 181 | P>T | No |
ExAC TOPMed gnomAD |
|
COSM1407330 | 182 | C>A | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs777328830 COSM112113 |
182 | C>L | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA |
rs1215345168 | 182 | C>S | No | Ensembl | |
TCGA novel | 184 | L>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs945064428 | 185 | R>Q | No |
TOPMed gnomAD |
|
rs1482064737 | 185 | R>W | No | gnomAD | |
rs1667223223 | 186 | K>Q | No | Ensembl | |
rs1286135753 | 188 | P>S | No | TOPMed | |
rs1286135753 | 188 | P>T | No | TOPMed | |
rs1413894866 | 189 | P>Q | No | gnomAD | |
rs1043008915 | 190 | S>L | No |
TOPMed gnomAD |
|
rs376613062 | 191 | A>P | No |
ESP ExAC gnomAD |
|
COSM5396775 rs771311276 |
192 | R>Q | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA TOPMed gnomAD |
rs1667224281 | 194 | G>S | No | Ensembl | |
rs151280427 | 195 | G>S | No |
ESP ExAC TOPMed gnomAD |
|
rs1572776956 | 196 | H>P | No | Ensembl | |
rs1572776956 | 196 | H>R | No | Ensembl | |
rs1667224981 | 197 | E>G | No | Ensembl | |
rs1274234223 | 202 | I>L | No | gnomAD | |
rs1667225274 | 203 | L>I | No | gnomAD | |
rs1287734269 | 204 | E>K | No | TOPMed | |
rs1319171778 | 207 | Q>R | No |
TOPMed gnomAD |
|
rs776475662 | 210 | V>M | No |
ExAC gnomAD |
|
rs1405825332 | 211 | D>G | No |
TOPMed gnomAD |
|
rs1405825332 | 211 | D>V | No |
TOPMed gnomAD |
|
rs1667230274 | 213 | K>Q | No | Ensembl | |
COSM3839235 | 215 | T>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs14628 | 216 | V>L | No | gnomAD | |
rs14628 | 216 | V>M | No | gnomAD | |
rs765039617 | 217 | D>N | No |
ExAC gnomAD |
|
rs1572777214 | 220 | E>G | No | Ensembl | |
rs1017481777 | 223 | R>C | No | Ensembl | |
COSM1407332 rs766068888 |
223 | R>H | Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] | No |
NCI-TCGA Cosmic cosmic curated Ensembl NCI-TCGA |
rs766068888 | 223 | R>L | No | Ensembl | |
rs1667230972 | 229 | K>Q | No |
TOPMed gnomAD |
|
TCGA novel rs1667231104 |
231 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Ensembl |
rs1191523736 | 231 | R>H | No | gnomAD | |
rs1438049103 | 234 | E>K | No | gnomAD | |
rs1160613040 | 236 | I>L | No | gnomAD | |
COSM1306654 | 236 | I>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1160613040 | 236 | I>V | No | gnomAD | |
rs756212692 | 237 | C>F | No |
ExAC gnomAD |
|
rs747380208 | 239 | E>D | No | gnomAD | |
rs1429195522 | 239 | E>Q | No |
TOPMed gnomAD |
|
rs751282252 | 242 | S>C | No | gnomAD | |
rs751282252 | 242 | S>G | No | gnomAD | |
rs1392031004 | 243 | E>K | No |
TOPMed gnomAD |
|
rs1181996605 | 244 | N>H | No | gnomAD | |
rs754348467 | 245 | S>T | No |
ExAC gnomAD |
|
rs757786832 | 246 | P>S | No |
ExAC gnomAD |
|
rs377651319 | 249 | S>L | No | Ensembl | |
rs376653902 | 252 | I>T | No |
ESP ExAC TOPMed gnomAD |
|
COSM184276 rs1027026616 |
263 | A>T | Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] | No |
cosmic curated NCI-TCGA TOPMed |
rs765906655 | 263 | A>V | No |
ExAC TOPMed gnomAD |
|
rs750965193 | 266 | E>K | No |
ExAC gnomAD |
|
rs1667241093 | 268 | D>G | No | Ensembl | |
rs780447671 | 268 | D>N | No |
ExAC TOPMed gnomAD |
|
rs1667241180 | 269 | E>G | No | TOPMed | |
rs1667241367 | 270 | I>T | No | Ensembl | |
rs370257698 | 272 | E>K | No |
ESP ExAC TOPMed gnomAD |
|
rs370257698 | 272 | E>Q | No |
ESP ExAC TOPMed gnomAD |
|
rs1342815990 | 274 | Q>K | No | gnomAD | |
rs1198147907 | 275 | Q>E | No |
TOPMed gnomAD |
|
rs780573850 | 275 | Q>H | No |
ExAC gnomAD |
|
rs1667242331 | 276 | E>K | No |
TOPMed gnomAD |
|
rs1667242419 | 278 | Q>R | No | TOPMed | |
rs149721958 | 280 | E>D | No | ESP | |
rs747598291 | 280 | E>K | No |
ExAC TOPMed gnomAD |
|
rs769280062 | 280 | E>V | No |
ExAC TOPMed gnomAD |
|
rs1667242903 | 281 | Y>* | No | gnomAD |
No associated diseases with Q9UPY8
8 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
microtubule cytoskeleton | The part of the cytoskeleton (the internal framework of a cell) composed of microtubules and associated proteins. |
microtubule organizing center | An intracellular structure that can catalyze gamma-tubulin-dependent microtubule nucleation and that can anchor microtubules by interacting with their minus ends, plus ends or sides. |
microtubule plus-end | The growing (plus) end of a microtubule. In vitro, microtubules polymerize more quickly at the plus end than at the minus end. In vivo, microtubule growth occurs only at the plus end, and the plus end switches between periods of growth and shortening, a behavior known as dynamic instability. |
midbody | A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis. |
mitotic spindle astral microtubule end | Any microtubule end that is part of a mitotic spindle astral microtubule. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
spindle midzone | The area in the center of the spindle where the spindle microtubules from opposite poles overlap. |
4 GO annotations of molecular function
Name | Definition |
---|---|
identical protein binding | Binding to an identical protein or proteins. |
microtubule binding | Binding to a microtubule, a filament composed of tubulin monomers. |
microtubule plus-end binding | Binding to the plus end of a microtubule. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
9 GO annotations of biological process
Name | Definition |
---|---|
cell division | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
positive regulation of cyclin-dependent protein serine/threonine kinase activity | Any process that activates or increases the frequency, rate or extent of CDK activity. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of protein kinase activity | Any process that activates or increases the frequency, rate or extent of protein kinase activity. |
protein localization | Any process in which a protein is transported to, or maintained in, a specific location. |
protein localization to microtubule | A process in which a protein is transported to, or maintained at, a microtubule. |
regulation of microtubule polymerization | Any process that modulates the frequency, rate or extent of microtubule polymerization. |
regulation of microtubule polymerization or depolymerization | Any process that modulates the frequency, rate or extent of microtubule polymerization or depolymerization by the addition or removal of tubulin heterodimers from a microtubule. |
spindle assembly | The aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart. |
12 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q3ZBD9 | MAPRE1 | Microtubule-associated protein RP/EB family member 1 | Bos taurus (Bovine) | SS |
Q5ZLC7 | MAPRE1 | Microtubule-associated protein RP/EB family member 1 | Gallus gallus (Chicken) | SS |
Q15555 | MAPRE2 | Microtubule-associated protein RP/EB family member 2 | Homo sapiens (Human) | PR |
Q15691 | MAPRE1 | Microtubule-associated protein RP/EB family member 1 | Homo sapiens (Human) | EV |
Q61166 | Mapre1 | Microtubule-associated protein RP/EB family member 1 | Mus musculus (Mouse) | SS |
Q8R001 | Mapre2 | Microtubule-associated protein RP/EB family member 2 | Mus musculus (Mouse) | PR |
Q6PER3 | Mapre3 | Microtubule-associated protein RP/EB family member 3 | Mus musculus (Mouse) | SS |
Q66HR2 | Mapre1 | Microtubule-associated protein RP/EB family member 1 | Rattus norvegicus (Rat) | SS |
Q5XIT1 | Mapre3 | Microtubule-associated protein RP/EB family member 3 | Rattus norvegicus (Rat) | SS |
Q9FJJ5 | EB1B | Microtubule-associated protein RP/EB family member 1B | Arabidopsis thaliana (Mouse-ear cress) | EV |
Q7XJ60 | EB1A | Microtubule-associated protein RP/EB family member 1A | Arabidopsis thaliana (Mouse-ear cress) | SS |
Q6P848 | mapre1 | Microtubule-associated protein RP/EB family member 1 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MAVNVYSTSV | TSENLSRHDM | LAWVNDSLHL | NYTKIEQLCS | GAAYCQFMDM | LFPGCVHLRK |
70 | 80 | 90 | 100 | 110 | 120 |
VKFQAKLEHE | YIHNFKVLQA | AFKKMGVDKI | IPVEKLVKGK | FQDNFEFIQW | FKKFFDANYD |
130 | 140 | 150 | 160 | 170 | 180 |
GKDYNPLLAR | QGQDVAPPPN | PGDQIFNKSK | KLIGTAVPQR | TSPTGPKNMQ | TSGRLSNVAP |
190 | 200 | 210 | 220 | 230 | 240 |
PCILRKNPPS | ARNGGHETDA | QILELNQQLV | DLKLTVDGLE | KERDFYFSKL | RDIELICQEH |
250 | 260 | 270 | 280 | ||
ESENSPVISG | IIGILYATEE | GFAPPEDDEI | EEHQQEDQDE | Y |